Legal & General Group PLC Pro Qr Therapeutics N.V. Transaction History

Legal & General Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$5.84 - $10.51 $326,555 - $587,687	-55,917 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$5.76 - $9.44 $63,504 - $104,076	-11,025 Reduced 16.47%	55,917 $323,000
Q4 2018 Feb 15, 2019	BUY	$15.25 - $22.4 $1.02 Million - $1.5 Million	66,942 New	66,942 $1.06 Million

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $191M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.